Status:

UNKNOWN

Association of Capecitabine Pharmacokinetics and Toxicity With Aging

Lead Sponsor:

Newcastle-upon-Tyne Hospitals NHS Trust

Collaborating Sponsors:

University of Newcastle Upon-Tyne

Conditions:

Breast Cancer

Colorectal Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This is a multi-centre prospective non-interventional study designed to evaluate the effects of patient age on the pharmacokinetics of capecitabine and its metabolites 5'DFCR, 5'DFUR, and 5-FU. In add...

Eligibility Criteria

Inclusion

  • 1\) Histologic or cytologic diagnosis of breast cancer or colorectal cancer. Patients should have disease that is suitable for capecitabine monotherapy as defined by the NICE Guidelines.
  • 2\) Patients must be within the first week of their first cycle of capecitabine treatment.
  • 3\) Estimated life expectancy of greater than 3 months. 4) Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2. 5) Total serum bilirubin less than or equal to 25 micromol/L. 6) Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels less than 2.5 times the upper limit of the normal range.
  • 7\) Serum albumin level greater than 32 g/L. 8) Creatinine clearance greater than or equal to 30 mL/minute. 9) Blood haemoglobin level of greater than 9 g/dL, with transfusion allowed. 10) Absolute neutrophil count greater than 2.5 x 109/L. 11) Platelet count greater than 100 x 109/L. 12) 18 years of age or older. 13) Written informed consent.

Exclusion

  • Pregnancy or breast feeding.
  • Known HIV, Hepatitis B, or Hepatitis C infection.
  • Known Gilbert syndrome.
  • Uncontrolled diabetes (HbA1c greater than 7.5%).
  • Any condition or disease that might affect oral absorption of medications, including:
  • Crohn's disease
  • Ulcerative colitis
  • Major gastric or small bowel resection
  • \-

Key Trial Info

Start Date :

May 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2019

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT03465202

Start Date

May 1 2016

End Date

November 1 2019

Last Update

March 14 2018

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.